A randomized trial evaluating an unmedicated acne-concealing hydrogel patch on the appearance of acne and its psychological impact on quality of life
Peer-Reviewed Publication
Updates every hour. Last Updated: 28-Jun-2026 22:15 ET (29-Jun-2026 02:15 GMT/UTC)
This randomized clinical trial provides clinical evidence supporting the efficacy of an unmedicated, acne-concealing hydrogel patch in improving both acne appearance and acne-related quality of life (AQoL). The study demonstrates that the hydrogel patch significantly reduces lesion size and severity within a short time frame, calms erythema, and helps prevent the development of post-inflammatory hyperpigmentation (PIH). Importantly, beyond visible skin improvements, the intervention led to a marked enhancement in participants’ psychological well-being, underscoring the value of non-pharmacological, barrier-based acne management strategies.
Alzheimer Europe has today launched the “The Prevalence of Dementia in Europe 2025” report, which provides updated prevalence figures for the number of people living with dementia both for Europe as a whole, as well as the countries within. The report builds upon Alzheimer Europe’s previous work in the “Dementia in Europe Yearbook 2019”.
Men begin developing coronary heart disease — which can lead to heart attacks — years earlier than women, with differences emerging as early as the mid-30s, according to a large, long-term study led by Northwestern Medicine. The findings, based on more than three decades of patient follow-up, suggest that heart disease prevention and screening should start earlier in adulthood, particularly for men.
Afternoon naps put the brain in a state ready for learning / Study performed in Freiburg, Germany shows the active role of short sleep phases in adjusting the strength of transmission between neurons
For several months now, the current U.S. administration has consistently attacked and endeavored to weaken biomedical research and public health action in the United States and worldwide with unparalleled vigor. This situation has many consequences – both ethical and economic – but above all it is a grave attack on healthcare protection, and an unprecedented assault on the systems and institutions responsible for protecting lives.
Patients with long COVID-19 in the U.S. report far higher rates of brain fog, depression and cognitive symptoms than patients in countries such as India and Nigeria, according to a large international study led by Northwestern Medicine.
The authors note that higher reported symptom burden in the U.S. may reflect lower stigma and greater access to neurological and mental health care, rather than more severe disease.